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Increased Expression of EMMPRIN and VEGF in the Rat Brain 
after Gamma Irradiation
The extracellular matrix metalloproteinase inducer (EMMPRIN) has been known to play a 
key regulatory role in pathological angiogenesis. A elevated activation of vascular 
endothelial growth factor (VEGF) following radiation injury has been shown to mediate 
blood-brain barrier (BBB) breakdown. However, the roles of EMMPRIN and VEGF in 
radiation-induced brain injury after gamma knife surgery (GKS) are not clearly understood. 
In this study, we investigated EMMPRIN changes in a rat model of radiation injury 
following GKS and examined potential associations between EMMPRIN and VEGF 
expression. Adult male rats were subjected to cerebral radiation injury by GKS under 
anesthesia. We found that EMMPRIN and VEGF expression were markedly upregulated in 
the target area at 8-12 weeks after GKS compared with the control group by western blot, 
immunohistochemistry, and RT-PCR analysis. Immunofluorescent double staining 
demonstrated that EMMPRIN signals colocalized with caspase-3 and VEGF-positive cells. 
Our data also demonstrated that increased EMMPRIN expression was correlated with 
increased VEGF levels in a temporal manner. This is the first study to show that EMMPRIN 
and VEGF may play a role in radiation injuries of the central nervous system after GKS.
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INTRODUCTION
The field of gamma knife surgery (GKS) is expanding in the treat-
ment of central nervous system disorders (1, 2). Radiation inju-
ry to the brain may lead to severe complications from acute, 
early and late reactions. Varying degrees of vascular changes 
including the modification of vascular structure and alterations 
in permeability can contribute to this pathological response (3). 
However, there are very limited data on the role of modifying 
factors associated with angiogenesis and vascular remodeling.
  Extracellular matrix metalloproteinase inducer (EMMPRIN) 
is a cell surface transmembrane glycoprotein that contains two 
extracellular immunoglobulin domains (C and V) and belongs 
to the immunoglobulin superfamily (4). EMMPRIN is known 
for its ability to induce matrix metalloproteinase (MMP) pro-
duction (5), which degrades the basement membrane of the 
original vessel and remodels the extracellular matrix (ECM) 
around neurovasculature sites. Recent studies have demonstrat-
ed that overexpression of EMMPRIN plays a critical role in myo-
cardial and renal injury induced by ischemia and reperfusion 
(6, 7). EMMPRIN has been reported to be associated with the 
pathogenesis of cerebral disorders such as ischemia and stroke, 
multiple sclerosis, and Alzheimer’s disease (8-10); however, no 
data are available that elucidate the role of EMMPRIN in radia-
tion injury. Various cytokines and growth factors have been 
shown to enhance the activities of EMMPRIN, such as epider-
mal growth factor (11) and transforming growth factor (12), and 
these cytokines (potentially capable of inﬂuencing EMMPRIN 
expression) have been reported to be increased within irradiat-
ed tissues (13). We therefore hypothesized that EMMPRIN ex-
pression in the irradiated brain can be upregulated and thus 
contribute to radiosurgically induced vascular injury.
  VEGF is a member of a family of angiogenesis-related growth 
factors. It is a highly conserved 36-46 kDa dimeric glycoprotein 
with potent and specific activity in promoting endothelial cell 
proliferation and vascular permeability. VEGF-induced increases 
in microvessel permeability have been demonstrated not only 
in normal brain endothelial cells but also in disease conditions, 
such as in tissues surrounding brain tumors (14) and ischemia 
lesions (15). Previous studies have found radiation-induced in-
creases of VEGF expression in regions of blood-spinal cord bar-
rier disruption after conventional radiotherapy (16). However, 
the radiobiological changes associated with radiosurgery are 
not the same as those observed in conventional radiotherapy 
with lower doses of radiation, and dynamic changes of VEGF 
after GKS in vivo have yet to be studied.Wei M, et al.  •  EMMPRIN and VEGF Expression after Gamma Irradiation
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  The aforementioned experimental results prompted us to  
investigate whether EMMPRIN and VEGF play important roles 
in radiosurgery-induced vascular disturbances. In the current 
study, the effect of GKS on the expression of EMMPRIN and 
VEGF was examined in the rat brain.
MATERIALS AND METHODS
Animal protocol
A total of ninety-six male Wistar rats weighing between 200 and 
240 g were housed individually in a temperature- (22°C) and 
humidity-controlled (60%) vivarium and maintained on a stan-
dard 12-hr light/dark cycle (7:00 a.m. to 7:00 p.m. per cycle) with 
free access to food and water. The rats were randomly assigned 
to control and GKS groups (48 rats per group). Four time points 
at 1, 4, 8, and 12 weeks after irradiation or sham-irradiation were 
analyzed for each study group. Experiments involving animals 
were approved by the Tianjin Medical University Animal Care 
and Ethics Committee.
Gamma Knife surgery
The radiation target and dosage were determined based on stud-
ies described previously (17). Briefly, each rat was anesthetized 
with 10% chloraldurat (3 mL/kg), and its head was fixed in a 
stereotactic brain frame. After high-resolution MR images were 
obtained, the center of the irradiation area was calculated with 
reference to a standard rat stereotactic atlas (X = 5, Y = 10, Z =  
6.5). A maximum dose of 75 Gy was administered in the right 
parietal cortex with a Leksell Gamma Knife (model C, Elekta 
Instrument AB , Stockholm, Sweden) using a 4-mm collimator. 
The control animals were identically manipulated but did not 
receive any radiation.
Histology and immunohistochemistry
The rats were perfused transcardially with 4% paraformaldehyde 
under intraperitoneal anesthesia; the brains were then removed 
and post-ﬁxed overnight at 4°C in 4% paraformaldehyde. The 
brains were cut at the target region and embedded in parafﬁn. 
A series of 4-µm thick paraffin sections were cut and mounted 
on the slides for further hematoxylin and eosin or immunohis-
tochemical staining. The sections were treated with standard 
1.5% horse or goat serum for 30 min, followed by an overnight 
incubation at 4°C with goat polyclonal anti-EMMPRIN (1:100; 
Santa Cruz Biotechnology, Santa Cruz, CA, USA) and mouse 
monoclonal anti-VEGF (1:100; Santa Cruz Biotechnology). After 
incubation with diluted biotinylated secondary antibody, the 
sections were incubated with ABC Reagent (Vector Laboratories, 
Burlingame, CA, USA) for 30 min, and visualized using 0.05% 
diaminobenzidine for 5-10 min. The positive cells were quan- 
tiﬁed from 10 random  × 400 ﬁelds in a blinded fashion. An iso-
type-matched negative control was used for all the antibodies.
Transmission electron microscopy
After perfusion, the parietal cortical tissue specimens at the sites 
of radiation were immediately excised. The radiation target was 
identified using the method previously described (17). Tissue 
blocks (1 μL) were excised and immersed in a fixative solution 
of 2% paraformaldehyde and 2.5% glutaraldehyde in 0.1 M/L 
phosphate buffer. The samples were dehydrated in a series of 
ethanol and transferred to 100% propylene oxide for 15 min, 
followed by graded resin infiltration and embedding. Ultrathin 
sections were prepared on a Leica Ultracut using a 45-degree 
diamond histoknife, and images were captured using a Hitachi 
H7650 Transmission Electron Microscope.
Water content analysis by dry/wet weight measurements
After the irradiated parietal cortices were carefully dissected, 
the tissues were weighed immediately and dried under vacuum 
for up to 2 weeks. The weights were measured throughout the 
drying period until no further change occurred. Water content 
was calculated as follows: Water content = (wet weight-dry 
weight)/wet weight 100 (%).
Evans blue (EB) extravasation
A 2% (w/v) solution of EB at 4 mL/kg was injected intravenous-
ly and allowed to circulate for 30 min. The brain EB extravasa-
tion was quantified spectrophotometrically. The brains were 
homogenized by vortexing in 250 µL of phosphate-buffered sa-
line (PBS) for 2 min. Then, 250 µL of 60% trichloroacetic acid 
was added, and the samples were vortexed for 2 min. After cool-
ing for 30 min, the samples were centrifuged for 5 min at 10,000 g. 
Absorbance readings were measured at 620 nm. EB extravasa-
tion results are expressed as ng of EB per mg of brain tissue. For 
qualitative examination of EB extravasation, the rats were per-
fused with 5 mL of saline followed by 5 mL of 4% paraformalde-
hyde. The removed brains were immersed in 30% sucrose in   
0.1 M PBS for 48 hr, frozen in OCT (Sigma Chemical Co., St. 
Louis, MO, USA), and stored at -80°C. The EB extravasation was 
observed in the cryostat sections (14 µm) using a fluorescent 
microscope.
Western blot analysis
Expression of EMMPRIN and VEGF protein was monitored at 
the indicated time points by Western blotting. The injured brain 
tissue was collected and homogenized with RIPA buffer contain-
ing protease inhibitors cocktail (Sigma), and then incubated for 
15 min on ice. The supernatant was isolated by centrifugation 
at 12,000 g for 20 min at 4°C. The concentration of total protein 
in each sample was quantitated by Bradford method (Bio-Rad, 
Hercules, CA, USA), as per the manufacturer’s instructions. Equal 
amounts of proteins were separated by SDS–PAGE, and then 
transferred to polyvinylidene difluoride membranes (Immobi-
lon-P; Millipore, Billerica, MA, USA) for 1 hr. The membrane Wei M, et al.  •  EMMPRIN and VEGF Expression after Gamma Irradiation
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was blocked for 1 hr and incubated with goat polyclonal anti-
EMMPRIN (1:200; Santa Cruz Biotechnology, Santa Cruz, CA) 
and mouse monoclonal anti-VEGF (1:200; Santa Cruz Biotech-
nology) in blocking solution at 4°C overnight. After triple wash-
ing, the membrane was incubated with horseradish peroxidase-
conjugated secondary antibody (1:2,000) at room temperature 
for 2 hr. In order to confirm equal protein loading, the blots were 
also reacted with antibodies against β-actin (Santa Cruz Biotech-
nology; 1:1,000). The target protein was detected using the ECL 
+ kit (Millipore).
Dual fluorescent staining
For double-immunofluorescence labeling, the cryostat sections 
were incubated with goat polyclonal antibody to EMMPRIN and 
mouse monoclonal antibody to VEGF or rabbit polyclonal anti-
body to caspase-3 (Chemicon, San Diego, CA, USA) overnight 
at 4°C. All slides were then washed repeatedly in PBS. Subse-
quently, the sections were incubated with the appropriate sec-
ondary antibody conjugated with fluorescent dyes (Alexa Fluor 
594 or Alexa Fluor 488; Molecular Probes, Inc., Eugene, OR, USA). 
The slides were visualized under a fluorescent microscope. In 
the negative controls, the primary antibody was substituted 
with PBS.
Statistical analysis
Data are expressed as the mean ± standard deviation (SD). Com-
parisons among multiple groups were performed using analy-
sis of variance (ANOVA) with Dunnett’s post hoc tests. Com-
parisons between the two treatment groups were made using 
Student’s t-test. The correlation between VEGF and EMMPRIN 
expression was analyzed using linear regression analysis. A P 
value of less than 0.05 was considered to be statistically signifi-
cant.
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Fig. 1. Radiation damage observed 12 weeks after irradiation. Upper left, drawing of a coronal section of the rat brain showing the isodose curve with a maximal center dose of 
75 Gy. (A and B) Photomicrographs of coronal sections stained with hematoxylin/eosin are shown from the irradiated (A) and nonirradiated (B) cortex. Enlarged vessels were ob-
served in GKS-irradiated regions. Scale bar = 250 µm. (C, D, and E) EB extravasation in the target region. The significant EB fluorescence (red) was observed in the target re-
gion (C). There was no EB fluorescence detected in the nonirradiated cortex (D). Scale bar = 50 µm. The EB concentration in the irradiated tissue was significantly higher than 
in the sham-operated group (F). (E) Ultrastructural observations of brain capillary endothelial cells. Changes included the enlargement of endothelial nuclei, pykno-chromatin (short 
arrow), process of the plasma membrane (short arrow) and astroglial edema (long arrow). A, astrocyte; EC, endothelial cell; N, nuclei; L, capillary lumen; BM, basement mem-
brane. (F) The brain water content in the parietal cortex increased in GKS groups compared with the controls. The data are presented as the mean ± SD. *P < 0.001 compared 
with the sham-operated group.Wei M, et al.  •  EMMPRIN and VEGF Expression after Gamma Irradiation
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RESULTS
Radiation-induced histological changes in brain tissue
In the present study, the parietal cortex was the target of unilat-
eral irradiation and the site of microscopic analyses. H&E stain-
ing and electron microscopy showed evidence of injury in brain 
tissue 12 weeks after irradiation (Fig. 1). The histological chang-
es were characterized by dilation of vessels, swelling of endo-
thelia cells and astrocytes, chromatin condensation and aggre-
gation, and destructive changes in membranous structures. 
Meanwhile, an increase in EB content and brain water content 
was also observed in irradiated tissue compared with the sham 
controls (6.64 ± 0.24 vs 2.42 ± 0.36 and 81.18 ± 0.57 vs 70.05 ±  
0.95, respectively; P < 0.001). Necrosis was not observed in the 
irradiated brain tissues, and no lesions were observed in the un-
irradiated controls.
Effects of GKS on expression of EMMPRIN in the rat brain
Immunohistochemical analysis of paraffin-embedded sections 
for EMMPRIN showed that in the parietal cortex, EMMPRIN 
was mainly observed in microvessel-like structures (Fig. 2). No 
significant differences were detected between the GKS and sham 
control groups at 1 and 4 weeks after GKS (P = 1.00). The num-
ber of EMMPRIN-positive cells was signiﬁcantly higher at 8 and 
12 weeks after GKS compared with the controls (7.25 ± 1.71 vs 
3.50 ± 1.00 and 11.00 ± 1.83 vs 3.75 ± 0.50; P < 0.001 for 8 and 
12 weeks compared with the injury controls).
  Western blot analysis showed that the EMMPRIN was detect-
ed as an immunoreactive band with a mean apparent molecu-
lar mass of approximately 50 kDa (Fig. 2). There was a signifi-
cant increase in EMMPRIN protein expression in the irradiated 
cortex after 8 weeks compared with the controls (0.54 ± 0.03 vs 
0.20 ± 0.02; P < 0.001) and was sustained at a higher level (0.70 ±  
0.01 vs 0.21 ± 0.02; P < 0.001) at 12 weeks after GKS.
  Real-time PCR was used to determine the gene expression of 
EMMPRIN in the control and GKS groups (Fig. 3). EMMPRIN 
levels signiﬁcantly increased in rats subjected to GKS compared 
with the sham control group (P < 0.001) at 8 and 12 weeks post-
radiation. EMMPRIN levels did not differ signiﬁcantly in both 
groups at 1 and 4 weeks post-radiation (P = 0.78 and P = 0.85).
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Fig. 2. Immunodetection of EMMPRIN after GKS. (A-F) Representative photomicrographs of EMMPRIN immunostaining in GKS-irradiated regions. Low baseline levels of EMMPRIN 
are observed in the sham-operated rat cortex (A), whereas EMMPRIN staining increases compared with the sham control at 8 and 12 weeks after GKS (B, C). (D-F) Higher 
magnification image of EMMPRIN signal. Arrows indicate positive EMMPRIN signal. Scale bar = 250 µm (A-C), or 50 µm (D-F). (G) Immunoblot of EMMPRIN protein expression 
in the damaged cortex after GKS. Bar graph shows the densitometric analysis of EMMPRIN-immunoreactive bands (H) and the temporal change of EMMPRIN-expressing cells 
after GKS (I). The data are presented as the mean ± SD. *P < 0.001 compared with the sham group.
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Effects of GKS on expression of VEGF in the rat brain
Immunohistological staining showed that the number of VEGF-
positive cells increased in the irradiated right parietal cortex at 
8 and 12 weeks after GKS (12.75 ± 2.22 and 18.50 ± 1.73, P <  
0.001; Fig. 4). By comparison, the number of VEGF-positive cells 
was low in brain tissues taken from the control rats (6.00 ± 1.41 
and 6.25 ± 1.50).
  To further examine the upregulation of VEGF, proteins obtained 
from homogenates of the rat brain tissue were used for western 
blot analysis. VEGF was visualized as a 21-kDa band, and VEGF 
protein contents were signiﬁcantly higher in rats treated with 
GKS compared with the control rats at 8 and 12 weeks after GKS 
(0.510 ± 0.01 vs 1.94 ± 0.01 and 0.621 ± 0.02 vs 0.197 ± 0.01; P <  
0.001; Fig. 4). There was no difference between the rats in the 
radiation groups and the control rats at 1 and 4 weeks after GKS 
(P = 0.66 and P = 0.51).
  Using real-time PCR analysis, VEGF mRNA from irradiated 
brain tissue was examined at 1, 4, 8, and 12 weeks after irradia-
tion and compared with the sham-irradiated controls. We de-
tected a statistically significant increase in VEGF mRNA (P <  
0.001; Fig. 5) in the irradiated brain tissue compared with the 
control brain tissue at 8 and 12 weeks after irradiation. At 1 and 
4 weeks post irradiation, both the control and irradiated brain 
tissues expressed approximately equal levels of VEGF mRNA 
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Fig. 4. Immunodetection of VEGF after GKS. (A-F) Representative photomicrographs of VEGF immunostaining after GKS. A few cells in the cortex of sham-operated rats are 
VEGF-positive (A). However, significant increases in expression of the VEGF occur in the irradiated cortex at 8 and 12 weeks after GKS (B, C). (D-F) Higher magnification image 
of the VEGF signal. Arrows indicate positive VEGF signal. Scale bar = 250 µm (A-C), or 50 µm (D-F). (G) Immunoblot analysis of VEGF protein expression in the damaged brain 
tissues 1 to 12 weeks after GKS. Bar graph shows the densitometric analysis of VEGF-immunoreactive bands (H) and the temporal change of VEGF (+) cells (I) after GKS. The 
data are presented as the mean ± SD. *P < 0.001 compared with the sham group.
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Fig. 3. Quantitative PCR analysis for EMMPRIN in the cortex ipsilateral to the irradia-
tion at 1, 4, 8, and 12 weeks after GKS. The average mRNA expression level in the 
sham brains was set to 1. Histogram and bars represent the mean ± SD of three 
replicas. *P < 0.001 compared with the sham group.
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(P = 0.71 and P = 0.30).
Co-localization of EMMPRIN and caspase-3 expression in 
the parietal cortex after GKS
Caspase-3 is a key factor leading to apoptosis and is often         
used as a marker of apoptosis. To determine if cells expressing 
EMMPRIN were undergoing caspase-3 activation after GKS, 
double-fluorescence immunohistochemistry was used to de-
tect the expression of EMMPRIN and caspase-3 on frozen sec-
tions. The overlap of signal between EMMPRIN and caspase-3 
was observed in the injured cortex from rats subjected to irradi-
ation. In the control group, there were only a few caspase-3-
positive cells in the corresponding region, and these cells were 
not immunopositive for EMMPRIN (Fig. 6).
Association between EMMPRIN and VEGF expression in 
the parietal cortex after GKS
To further understand the relationship between EMMPRIN and 
VEGF expression in the irradiated brain, we used a double-im-
munofluorescence technique to investigate whether EMMPRIN 
co-localized with VEGF. There were a few EMMPRIN-positive 
cells (Fig. 7) in the control group, and these cells were not im-
munopositive for VEGF (Fig. 7). However, EMMPRIN staining 
colocalized with VEGF staining in the vascular lumen-like struc-
ture in the GKS group at 12 weeks after GKS (Fig. 7F). In addi-
tion, VEGF expression significantly correlated with EMMPRIN 
expression by linear regression correlation analysis (R
2 = 0.822, 
P < 0.001). These data suggested that enhanced expression of 
Fig. 5. Quantitative PCR analysis for VEGF in the cortex ipsilateral to the irradiation at 
1, 4, 8, and 12 weeks after GKS. The average mRNA expression level in the sham 
brains was set to 1. Histogram and bars represent the mean ± SD of three replicas. 
*P < 0.001 compared with the sham group.
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Fig. 6. Representative microphotographs of immunofluorescence double staining for EMMPRIN (red) and caspase-3 immunoreactivity (green) in the target region. Colocalization 
of EMMPRIN (A) and caspase-3 (B) was observed in the irradiated cortex following GKS. C is a merged image of A and B. No double-labeling was found in the control groups (D). 
Scale bar = 50 µm.
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EMMPRIN may increase VEGF levels in irradiated brain tissues.
DISCUSSION
Using Gamma Unit C model of the Leksell stereotactic system, 
irradiation of the right parietal cortex was accomplished, and 
the targeting accuracy was conﬁrmed (17). According to pub-
lished radiobiological studies, an intermediate dose of focal gam-
ma-irradiation elicits vascular alterations at 3 months post-irra-
diation without necrosis (17). Similar results were observed in 
the present study, in which rats subjected to experimental GKS 
showed structural and functional changes in the cerebral micro-
vasculature, including the dilation of vessels, morphological 
damage to endothelial cells and perivascular elements, and an 
increase in vascular permeability. These vascular injuries may 
be closely related to increased matrix degradation in the vessel 
walls and overstimulation of proangiogenic factors in the in-
jured tissue (18).
  Data revealed that EMMPRIN expression significantly in-
creased in the irradiated rat cortex after GKS, indicating that 
EMMPRIN was likely to be correlated with radiation injury after 
GKS. Although there have been no reported studies to investi-
gate EMMPRIN expression in normal brain tissue after radio-
surgery or traditional radiotherapy, EMMPRIN expression has 
been found in many types of normal tissues, including the brain. 
On a cellular level, EMMPRIN is identified on the surface of cul-
tured endothelial cells, suggesting that this molecule may play 
a role in angiogenic function (19). In the normal central nervous 
system(CNS) tissues, EMMPRIN has been found in endothelial 
cells and has been linked to CNS regulation and functions such 
as embryonal blood-brain barrier development and integrin-
mediated adhesion in brain endothelia (20). Moreover, most 
studies have concentrated on the effect of EMMPRIN on patho-
logical conditions because its apparent upregulation is observed 
in a wide variety of fatal diseases, such as malignant tumors, 
cerebrovascular disease, and heart disease. A recent study dem-
onstrated that ischemia-induced EMMPRIN expression might 
contribute to neurovascular remodeling in a mouse model of 
permanent middle cerebral artery occlusion (8). Excessive ex-
pression of EMMPRIN has also been associated with damage 
of the basal lamina following transient ischemia (21). In addi-
tion, previous researchers have found that the EMMPRIN mole-
cule is highly expressed on the surface of various malignant tu-
mor cells and have aimed at the role of EMMPRIN during path-
ological angiogenesis in these cancers (22). The functional im-
portance of EMMPRIN in pathological conditions has been re-
lated mainly to its ability to induce proteases such as MMPs (23) 
and the urokinase-type plasminogen activation system (uPA) 
(24). Normally, proteases are thought to represent a key role in 
ECM degradation and remodeling, which are essential for angio-
genesis. However, proteases have been reported to contribute 
to caspase-mediated brain endothelial cell death (25). Further-
more, proteolytic breakdown of the blood-brain barrier (BBB) 
vasculature also increases the permeability of the barrier result-
ing in vasogenic edema and is thought to play an active part in 
the pathophysiology of CNS diseases (26). In the present study, 
EMMPRIN- immunopositive cells were double-immunoposi-
tive for caspase-3, a major apoptotic factor, in the injured cortex 
following GKS. Increased EMMPRIN may not only be an initial 
factor leading to endothelial injury but also a parameter of ad-
vanced destruction in apoptotic cells through the stimulation 
of protease production. The increase of EMMPRIN in irradiated 
brain tissues (2.9 times higher than in the sham-treated animals) 
would very likely contribute to the abnormalities in vascular ar-
chitecture and increased vascular permeability beyond its nor-
mal physiological role and eventually lead to disturbed blood 
ﬂow, metabolic disruptions, and histological changes.
  Here, we showed that VEGF expression was also induced by 
radiosurgery in the normal radiated brain in the subacute stage, 
reaching maximum levels at 12 weeks after radiosurgery. The 
pattern of mRNA expression levels in irradiated tissues was sim-
ilar to that of protein expression levels. The maximum expres-
sion of VEGF coincided with both the peak in brain edema and 
the EB extravasation ratio. The temporal and spatial association 
of increased VEGF protein expression and vascular lesions sug-
gests that VEGF upregulation is associated with an increase in 
vascular permeability and edema resulting from GKS injury. This 
is similar to the findings of a previous conventional radiothera-
py study in which VEGF expression in the spinal cord was pres-
ent at 16-20 weeks after irradiation with 22 Gy, a time at which 
significant blood-spinal cord barrier breakdown is observed (27). 
Interestingly, VEGF colocalized with EMMPRIN expressed on 
endothelial-like cells, and changes in VEGF expression were sig-
nificantly correlated with EMMPRIN levels in the injured brain 
of rats receiving GKS. Although the biological and clinical signif-
icance of the overexpression of VEGF and EMMPRIN is unclear, 
the deleterious role of coexpression of VEGF and EMMPRIN has 
been indicated by the correlation with primary tumors and met-
astatic rates as well as the poor prognosis for patients with spe-
cific malignant tumors. Those patients with VEGF+/EMMPRIN+ 
co-expression showed signiﬁcantly shorter overall survival and 
disease-free survival compared with those of VEGF-/EMMPRIN- 
expression (28). EMMPRIN-mediated VEGF production likely 
occurs at different levels, and as noted previously, the increased 
EMMPRIN in tumor cells is also thought to upregulate VEGF 
expression in these cells and promote tumor angiogenesis (29). 
EMMPRIN can also promote angiogenesis by a direct effect on 
endothelial cells through a regulation of the VEGF/VEGF-recep-
tor (VEGFR) system (30). Although evidence thus far is limited to 
correlative expression patterns, a direct involvement of EMMPRIN 
in the regulation of VEGF in irradiated brain tissues seems like-
ly and warrants further investigation. Moreover, it is not entirely Wei M, et al.  •  EMMPRIN and VEGF Expression after Gamma Irradiation
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clear how VEGF operates in synergy with EMMPRIN. It is tempt-
ing to hypothesize that EMMPRIN might not only provide the 
support to degrade the extracellular matrix in the radiated brain 
tissue but also induce BBB permeability and aggravate the radi-
ation-induced vessel injury by upregulating VEGF expression 
in the target region after GKS. This represents one of the possi-
ble mechanisms underlying radiation injury following GKS.
  In summary, this is the first study to examine the role of 
EMMPRIN in CNS radiation injury. Although we cannot ex-
clude the possibility that EMMPRIN has other functions within 
the CNS post-irradiation, our results suggest that the increases 
in EMMPRIN and VEGF might be at least partially related to 
vascular damage after GKS. Future studies should focus on how 
to modulate the combined action of EMMPRIN and VEGF dur-
ing the different phases of radiation injury.
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